(Q45880144)

17 December 2017

reason for preferred rank

title

Interaction of interferon-α with interleukin-1β or tumor necrosis factor-α on hepatitis B virus enhancer activity (English)

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

2 December 2023

Interaction of interferon-alpha with interleukin-1 beta or tumor necrosis factor-alpha on hepatitis B virus enhancer activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312844

2 December 2023

1 reference

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

2 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

2 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

2 December 2023

10

S. Nagataki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312844

2 December 2023

author name string

K. Hamasaki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312844

2 December 2023

K. Nakata

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312844

2 December 2023

K. Nakao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312844

2 December 2023

S. Mitsuoka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312844

2 December 2023

T. Tsutsumi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312844

2 December 2023

Y. Kato

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312844

2 December 2023

M. Shima

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312844

2 December 2023

N. Ishii

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312844

2 December 2023

T. Tamaoki

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312844

2 December 2023

language of work or name

English

0 references

publication date

1 March 1992

1 reference

17 December 2017

16 March 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1312844

full work available at URL

2 December 2023

https://api.elsevier.com/content/article/PII:0006291X92905697?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

https://api.elsevier.com/content/article/PII:0006291X92905697?httpAccept=text/plain

2 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

Biochemical and Biophysical Research Communications

2 December 2023

published in

1 reference

17 December 2017

volume

183

1 reference

17 December 2017

page(s)

904-909

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

Relation of the hepatitis B virus carrier state to hepatocellular carcinoma

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

Suppression of HBsAg production in PLC/PRF/5 human hepatoma cell line by interferons

2 December 2023

2

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life

2 December 2023

3

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

Long-term remission of chronic hepatitis B after alpha-interferon therapy

2 December 2023

5

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1.

2 December 2023

6

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

Antiviral effects of recombinant tumour necrosis factor in vitro

2 December 2023

7

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

Spontaneous production of tumour necrosis factor alpha and interleukin-1 beta during interferon-alpha treatment of chronic HBV infection

2 December 2023

8

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

A method for isolation of intact, translationally active ribonucleic acid.

2 December 2023

12

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

Cloning and structural analyses of hepatitis B virus DNAs, subtype adr.

2 December 2023

13

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

The enhancer sequence of human hepatitis B virus can enhance the activity of its surface gene promoter

2 December 2023

16

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons

2 December 2023

18

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2',5'-adenylate synthetase

2 December 2023

19

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

The molecular biology of the hepatitis B viruses

2 December 2023

21

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

Interferon inhibits hepatitis B virus replication in a stable expression system of transfected viral DNA.

2 December 2023

23

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection.

2 December 2023

27

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease

2 December 2023

28

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection

2 December 2023

29

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure

2 December 2023

30

1 reference

https://api.crossref.org/works/10.1016/0006-291X(92)90569-7

2 December 2023

Identifiers

1 reference

17 December 2017

1 reference

17 December 2017